Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Long sensing the way the winds were changing on attitudes to cigarettes, the industry has been pivoting to new products, such ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...